Abstract -The purpose of the present study was to examine the processes underlying relapse to drinking using objective biological validation of self-reported recent alcohol consumption, using the ratio of 5-hydroxytryptophol to 5-hydroxyindol-3-ylacetic acid (5-HTOL/5-HIAA), a new biological marker to detect single episodes of drinking, in a sample of 38 male alcohol-dependent patients (DSMm-R) who were assessed prospectively in terms of their clinical symptomatology over a 6-month treatment period Results showed that nearly all patients obtained positive 5-HTOI75-HIAA samples during the course of treatment. However, upon closer inspection, results revealed a bimodal distribution for alcohol intake with high and low frequency of consumption episodes. Results showed that high frequency consumers obtained higher ratings of clinical symptoms as measured by the Comprehensive Psychopathological Rating Scale (CPRS) and by the St Goran's Semi-structured Interview (SGSI) compared to low frequency alcohol consumers on symptoms of inner tension, lack of initiative, risk of relapse (as rated by therapists and as rated by patients themselves), dysphoria, negative craving for alcohol, and positive craving for alcohol. The present results provided evidence for the existence of two sub-populations of alcoholics, those who have frequent lapses and those who have low frequency of sporadic lapses. Further, these two sub-populations were shown to differ with respect to overall psychological functioning, and craving for alcohol. In conclusion, the present findings have important treatment implications in that reliable identification of patients' consumption patterns using biological markers would allow for the design of individually tailored treatment needs.
INTRODUCTION
treatment (Armor et al., 1978; Gottheil et al., 1992) . Similar rates for the maintenance of In alcoholics, periods of abstinence are frequently sobriety have also been reported for clients seen followed by craving for alcohol and relapse to on an individual out-patient basis (Annis, 1986 ; problem or non-problem drinking (Emerick and Litman et al., 1979a) . Hansen, 1983) . In fact, relapse into alcohol abuse In order to develop more effective treatment after a period of abstinence is one of the major and prevention strategies, typologies have been problems faced by both clinicians and researchers developed which define subtypes of more homoin the treatment of alcoholism (Marlatt and geneous groups of alcoholics who might, on the Donavan, 1981). A major challenge in the field basis of treatment-matching, benefit from specific of alcoholism is the improved understanding of the forms of treatment. These typologies typically relapse process leading to more effective methods conceptualize alcoholism as multi-dimensional, of treatment and prevention strategies (Mackay and thus encompass multiple characteristics and Marlatt, 1990-91) . Relapse rates as high as including aetiology, pattern of drinking, type and 50-60% have been reported within the first 3 severity of dependence, genetic vulnerability, months following in-patient treatment and 80% or personality profiles, and the role of psychopathomore by 6 months following discharge from logical dysfunction. Examples of these typologies include Cloninger's neurological learning model (Cloninger, 1987) , Morey and Skinner's hybrid model ^Oiey and Skinner, 1986 ) and Zucker's
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Alcohol and Drug Dependence Unit, St Gorans Hospital, Box developmental model (Zucker, 1987) . 12557, S-102 29 Stockholm Sweden. However, regardless of the typology used, there 429 is a general agreement in the literature that the common precipitants or mediating factors related to relapse are a combination of individual, situational, and physiological factors (Brownell et al, 1986) . Findings from studies that have focused on individual and intrapersonal factors in the mediation of relapse suggest that negative emotional states including feelings of frustration, anger, anxiety, depression, and boredom (Booth et al, 1991; Cummings et al., 1980; Kivlahan et al, 1983; Rychtarik et al, 1992; Leibenluft et al, 1993) mediate lapses into alcohol consumption. One factor that has been found to be related to positive outcome is self-efficacy, coping skills or the ability to adapt to internal or external demands or stressors (Litman et al, 1979a; Kivlahan et al, 1983; Annis and Davis, 1988; Rychtarik et al, 1992) . Situational, social and environmental factors, such as social pressure or lack of social support, have also been found to predict relapse (Cummings et al., 1980; Moos and Finney, 1983) . Physiological factors have also been found to be important determinants in the relapse process (Brownell et al, 1986) . The severity of physical dependence, craving, and withdrawal symptom severity have all been reported to be related to the propensity to relapse (Stockwell et al., 1982; Booth et al, 1991; O'Connor et al, 1991) .
Few studies, however, have employed a prospective longitudinal design to study the process of relapse or the alcohol dependence syndrome during long-term abstinence (Litman, 1974; Litman et al, \919b; Fishbein et al, 1993) . Further, the majority of studies have relied on selfreport data of alcohol consumption from the subjects themselves or collateral informants, or, if available, by using data from official records (Makelae, 1982; Midanik, 1982; Sanchez-Craig and Annis, 1982; Room, 1990) . However, the drinking pattern and the amount of alcohol consumed are not always related to the reported drinking behaviour (Robinson et al, 1979; Freeberg and Johnston, 1980; Midanik, 1982; Watson et al, 1984) . Furthermore, studies utilizing objective validation of alcohol consumption by using biological markers have been rare in the literature (Makelae, 1982; Midanik, 1982; Sanchez-Craig and Annis, 1982; Room, 1990) .
In order to study the processes underlying relapse to drinking, using objective biological validation of self-reported recent alcohol consumption, a sample of alcohol-dependent males was assessed prospectively in terms of their clinical symptomatology over a 6-month time period following in-patient treatment. Patients were assessed three times a week on an outpatient basis over a 26-week period. Biological validation of self-reported episodes of recent alcohol consumption was carried out via ratio of urinary 5-hydroxytryptophol to 5-hydroxyindol-3-ylacetic acid (5-HTOL/5-HIAA), a new biological marker to detect single episodes of drinking (Voltaire et al., 1992; Helander et al, 1993) . The 5-HTOL/5-HIAA ratio has previously been shown to be a reliable biological marker in the validation of clinical information in alcoholdependent patients (Voltaire-Carlsson et al, 1993) . Patients were assessed in terms of their overall psychological functioning, craving for alcohol, and possible autonomic disturbances.
MATERIALS AND METHODS

Subjects
The sample consisted of 38 male patients (age, mean ± SD: 44.2 ± 7.5; range: 28-61 years) who were classified as alcohol-dependent according to DSM-IH-R criteria (American Psychiatric Association, 1987) . Users of psychoactive medication were excluded from the present study, as were patients with a past or with a current psychiatric or somatic disorder. Subjects were matched for their psychiatric co-morbidity. Similarly, patients who showed any clinical signs of liver disease were also excluded from the present sample. Although subjects were typically married, had completed high school, were presently employed, had a history of steady employment, and came from middle class backgrounds, they were at high risk of losing their, employment, friends and family due to their alcohol consumption.
Materials
Psychiatric symptoms were rated using the Comprehensive Psychopathological Rating Scale (CPRS) which was originally developed by Asberg et al (1978) . The CPRS has been widely used in the assessment and in the treatment of psychopathology in a variety of settings (Axelsson et al., 1991; Bertschy et al, 1992) . It has also received cross-cultural validation (Bertschy et al, •Student's r-tesL tFisher's exact probability test. {Kendall's Tau. Difficulty of concentration Main effect of time:
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Overall, high frequency alcohol consumers had significantly higher ratings compared to low frequency alcohol consumers. Overall, mean ratings of positive craving were significantly higher at week 3 compared to week 5. At weeks 2, 3, 4, 10, 11, 15, 16, 18, 21, 23 and 24 high frequency alcohol consumers had significantly higher ratings compared to low frequency alcohol consumers. Furthermore, high frequency alcohol consumers showed a significant attenuation in their ratings of positive craving for alcohol from week 3 to week 7, and a significant augmentation from week 7 to week 11.
Overall, high frequency alcohol consumers had significantly higher ratings compared to low frequency alcohol consumers. Overall, mean ratings of negative craving were significantly higher at week 1 and at week 2 compared to weeks 6, 7 and 8, when a decrease was observed. At weeks 10, 16, 18, 19, 20, 22 and 23 high frequency alcohol consumers had significantly higher ratings compared to low frequency alcohol consumers. Furthermore, high frequency alcohol consumers showed a significant augmentation in their ratings of negative craving for alcohol from week 8 to week 11.
Overall, high frequency alcohol consumers had significantly higher ratings of dysphoria compared to low frequency alcohol consumers. A tendency to higher ratings of dysphoria in high frequency alcohol consumers compared to low frequency alcohol consumers at week 10; however, this was not significant (P = 0.066).
Overall, mean ratings for concentration difficulties were significantly higher at week 1 and at week 2 compared to week 13.
At week 18 high frequency consumers had higher ratings compared with low frequency alcohol consumers. Furthermore, high frequency alcohol consumers showed a significant attenuation in their ratings from week 9 to week 14, a significant augmentation from week 17 to week 18, followed by a significant decrease from week 18 to week 20.
Overall, high frequency alcohol consumers had significantly higher ratings compared to low frequency alcohol consumers. High frequency alcohol consumers had significantly higher ratings at week 18 compared to ratings of low frequency alcohol consumers at week 20.
Overall, high frequency alcohol consumers reported significantly higher ratings of risk of relapse compared to low frequency alcohol consumers.
Overall, high frequency alcohol consumers had significantly higher ratings of risk of relapse compared to low frequency alcohol consumers. At weeks 19, 24, 25 and 26 high frequency alcohol consumers had significantly higher therapists' ratings of relapse risk compared to low frequency alcohol consumers. Furthermore, high frequency alcohol consumers received significantly higher ratings for risk of relapse from week 8 to week 25.
1992). Seventeen symptoms were rated using the CPRS (Asberg et al., 1978) . A score of > 1.0 per item on the CPRS (Asberg et al, 1978) was considered as indicative of the presence of clinical symptomatology. The St GOran's semi-structured interview (SGSI) was used to obtain demographic information, medical history, prescription and non-prescription drug usage, alcohol consumption history, positive and negative craving for alcohol (defined as urges, desire, and need for alcohol), thoughts and emotions related to alcohol consumption, relapse and abstention, risk of relapse as rated by the therapists, risk of relapse as rated by the patients themselves, and behaviour (including absence, punctuality, haste, eye-contact, complaints, and restlessness) during the interview itself (Voltaire-Carlsson et ai, 1994) .
Procedure
Patients were recruited from the psychiatric emergency ward at St Goran's Hospital in Stockholm or via advertisement in the local press of the Stockholm area. The patients were treated for acute withdrawal for a 7-14-day period. Applicants were asked to partake in an initial assessment and were screened for inclusion in the present study. Those who qualified for participation in the present treatment programme were provided with information about the present study and treatment programme and informed consent for participation was obtained. The treatment team consisted of two psychiatrists, one psychologist and trained psychiatric nurses. Patients attended a comprehensive 6-month treatment programme and were seen on an out-patient basis three times per week. The treatment programme consisted of individual supportive psychotherapy with a focus on relapse prevention, clinical assessments via semi-structured interviews and daily urine sampling. Biochemical validation of self-reported use of alcohol, sedative hypnotics and/or illicit drug use were obtained via 5-HTOL/5-HIAA sampling and urinary toxic screening for other drug metabolites.
Biochemical analysis
Determination of 5-HTOL in urine involved hydrolysis of conjugates by beta-glucuronidase, solvent extraction, and preparation of pentafluoropropionyl derivatives, followed by capillary column gas chromatographic-mass spectrometric analysis (Voltaire et ai, 1992) . 5-HIAA in urine was determined by direct injection of urine into a reversed-phase HPLC system with electrochemical detection (Helander et ai, 1991) .
Statistical analysis
Results were analysed statistically using various appropriate procedures as indicated with the relevant results.
RESULTS
Subjects and sub-group differences
Results from the biochemical analyses showed that nearly all 38 subjects tested positive for elevated 5-HTOL/5-HIAA ratios. From the 38 subjects, the 11 subjects with the lowest drinking frequency and the 11 with the highest were selected as two sub-groups with which the study was continued (see Table 1 ). The selection criteria were based on the frequency of alcohol consumption episodes as determined by elevated 5-HTOL/ 5-HIAA ratios during the 180 days of the present study. Background characteristics of subjects in the two groups are presented in Table 2 . None of the characteristics presented, including variables measuring withdrawal severity, was able to significantly differentiate the two groups from each other (see Table 2 ).
In order to determine whether low-and highfrequency consumers differed in terms of percentage of drinking days, an ANCOVA was computed using 'days in project' as a covariate. Results showed that the two groups differed significantly [F(l,19) = 44.34, P < 0.0001] from each other in terms of percentage of drinking days. In order to determine potential group differences in symptoms, 2 (group: low versus high frequency of alcohol consumption) x 26 (time: weeks) analysis of variance (ANOVA, run by the GLM-procedure in SAS software, SAS Institute Inc., Cary, NC, USA), with the last factor as repeated measure, were computed for each of the respective symptoms. To control for alpha-inflation, the Bonferroni correction was used. Post-hoc comparisons were carried out using Tukey's HSD tests (Cohen and Cohen, 1989) , and the results of these post-hoc comparisons are shown in Table 3 .
Craving (Fig. 1) For positive craving (positive thoughts, expectations and dreams associated with alcohol), the results of the ANOVA revealed a significant main effect for group [F(l, 20) (Fig. 2) For dysphoria, results of the ANOVA revealed a significant main effect for group [F(l, 20) = 4.90, P < 0.04]. The main effect for time was not significant. However, the group x time interaction was significant [F(25, 425) = 1.67, P < 0.03]. For concentration difficulties, no significant main effect was found for group; however, results from the ANOVA revealed a significant main The group x time interaction was not significant. For lack of initiative, no significant main effect was found for group; however, results from the ANOVA revealed a significant main effect for time [F(25, 425) (Fig. 3) For risk of relapse, according to patients, ANOVA revealed a significant main effect for group [F(l, 20) = 9.60, P < 0.01]. The main effects for time and the group x time interaction were not significant.
Dysphoria, concentration, initiative and inner tension
Risk of Relapse
For risk of relapse, according to therapists, results of ANOVA revealed a significant main effect for group [F(l, 20) = 10.32, P < 0.005], the main effect for time was not significant. However, the group x time interaction was significant [F(25, 425) = 2.50, P < 0.0001].
No significant effects were found for improvement in concentration, irritability, sleep disturbances, humour, initiative, fatigue, improvement in sleep, persistence, autonomic disturbances, increased memory, decreased memory, pessimistic thoughts, euphoria, or behaviour during treatment sessions (i.e. eye-contact, punctuality etc.).
DISCUSSION
The purpose of the present study was to examine the processes underlying relapse to drinking using objective biological validation of self-reported recent alcohol consumption in a sample of alcohol-dependent males who were assessed prospectively in terms of their clinical symptomatology over a 6-month treatment period. The results showed that nearly all patients obtained positive 5-HTOL/5-H1AA ratios during the course of treatment. However, upon closer inspection, results revealed a bimodal distribution for alcohol intake with low and high frequency of consumption episodes. Although it is noteworthy that the sample size of the present study consisted of only 11 subjects per group, these findings are nevertheless consistent with those in the literature describing typologies or sub-types of alcoholics (Morey and Skinner, 1986; Cloninger, 1987; Zucker, 1987) . Further analysis of the clinical symptoms as measured by the CPRS and the SGSI revealed that low-and high-frequency alcohol consumers differed with respect to presenting clinical symptomatology. More specifically, these two sub-groups of alcohol consumers were shown to differ in overall psychological functioning, craving for alcohol and risk of relapse during a 6-month treatment period.
Overall, the current findings showed consistent differences in symptomatology between low and high frequency alcohol consumers. High frequency alcohol consumers as compared with low frequency consumers obtained consistently higher scores on positive craving and negative craving for alcohol, dysphoria, lack of initiative, inner tension, risk of relapse as rated by patients, and risk of relapse as rated by therapist throughout the 6-month treatment period.
It is interesting to note that, regardless of type of consumer, treatment effects were found for concentration difficulties, and positive and negative craving for alcohol. No differences between groups or effects of time in treatment were found for improvement in concentration, good humour, initiative, fatigue, improvement in sleep, persistence, irritation, autonomic and sleep disturbances, increased and decreased memory, pessimistic thoughts, euphoria, and behaviour during treatment sessions.
Given that subjects were matched on the basis of situational, social, and environmental factors, as well as psychiatric co-morbidity, the present findings suggest that, regardless of the latter factors or psychiatric history, but rather, as a direct consequence of the number of drinking episodes, the most consistent differences were found in craving for alcohol, relapse, mood, and anxiety. Thus, our findings are inconsistent with other lines of research suggesting that factors such as social pressure or lack of social support mediate relapse (Brownell et al, 1986) . This finding may be due to the fact that our sample consisted of highly functioning, societal, socially and psychologically alcohol-dependent patients. However, our results stand in agreement with those emphasizing the role of individual and intrapersonal factors in the mediation of lapses into alcohol consumption (Cummings et al, 1980; Kivlahan et al., 1983; Booth et al., 1991; Rychtarik et al, 1992; Leibenluft etal, 1993) . More specifically, it has been suggested that negative emotional states, including feelings of anger, anxiety and depression, mediate the re-initiation of alcohol intake in patients. Furthermore, the present findings are also consistent with results from studies elucidating the role of craving and/or degree of withdrawal severity as determinants in the relapse process (Stockwell et al, 1982; Booth et al, 1991; O'Connor et al, 1991) , in that our findings showed consistent differences in negative and positive craving for alcohol between low-and high-frequency alcohol consumers. Degree of positive and negative craving, and other related withdrawal symptoms, could be used in conjunction with data from biological markers to identify individuals who may be at risk for potential relapse, complications in treatment, and/or treatment failure. Further, the role of craving, or the intense anticipation, desire, or urge for a drug, states of anxiety, affective states, and relapse in the mediation of the relapse process support the hypothesis that underlying personality traits such as the regulation of affective states rather than individual psychiatric symptoms, may be important factors in the dependency process.
In conclusion, the most consistent differences between high-and low-frequency alcohol consumers were found with regard to craving, mood, anxiety, and risk of relapse. These results suggest that even in a sample of alcohol-dependent patients with stable social and economic conditions, differences in psychological functioning and risk of relapse were obtained when these individuals were monitored prospectively over a 6-month time span. These findings further suggest that daily monitoring of alcohol intake using biological markers may reveal differential treatment needs for these two sub-populations. Additionally, it is interesting to note that, although abstinence was advocated as a treatment requirement for patients, nearly all patients ingested alcohol throughout the treatment period. These results further support the value of advocating abstinence as a requirement for admission to treatment, and further, as a goal of treatment at least during the initial 6-month period following initiation of treatment. Taken together, the present findings have important treatment implications in that reliable identification of patients' consumption patterns using biological markers would help identify high-risk patients and further allow for the design of individually tailored treatment needs.
